Skip to content
#gene editing Review Open access

The Asian perspective on xenotransplantation: bridging the organ gap through regional collaboration and tailored clinical protocols

Sep 2026 · Clinical transplantation and research · Vol 40, pp. 451 - 463 · 0 citations · 45 references
Medicine

TL;DR

A distinct "Asian way" of xenotransplantation is proposed that integrates scientific excellence with cultural diversity and regional solidarity to shape the future of transplantation medicine.

Abstract

Xenotransplantation using genetically engineered porcine organs has emerged as a transformative strategy to address the critical organ shortage crisis in Asia, where low deceased donation rates and high disease burden create a persistent supply-demand gap. This review examines the Asian perspective on xenotransplantation across five domains: sociocultural acceptance, technical advances in multigene-edited pig platforms, clinical protocol optimization for Asian recipients, regulatory harmonization through the Asian Xenotransplantation Association, and infrastructure development including hybrid clinical centers and capacity-building initiatives. Asian countries, particularly China, South Korea, and Japan, have demonstrated substantial progress in gene editing, designated pathogen-free breeding, and translational research. However, clinical success requires region-specific immunosuppressive protocols, pharmacogenomic adaptation, endemic infectious disease surveillance, and culturally sensitive public engagement. Regional collaboration through harmonized regulatory frameworks, multinational trial networks, and equitable access models will be essential to ensure that xenotransplantation benefits all Asian populations. This review proposes a distinct "Asian way" that integrates scientific excellence with cultural diversity and regional solidarity to shape the future of transplantation medicine.

Read PDF

Similar papers

Review Open access Sep 2026

The xenotransplantation hybrid hospital: structural, economic, and regulatory frameworks for zero-ischemia clinical translation

Xenotransplantation using genetically engineered porcine organs offers a solution to the global organ shortage. However, the extreme vulnerability of porcine xenografts to ischemia-reperfusion injury (IRI) poses a barrier that conventional transplant infrastructure cannot overcome. We evaluated the architectural, biolo...

Ik-Jin Yun · 0 citations
Review Open access Sep 2026

Xenotransplantation of the Porcine Lung—From Immunological Barriers to Emerging Experimental Strategies

This review summarizes the current knowledge on immunological barriers in lung xenotransplantation, including mechanisms of hyperacute, delayed, and chronic rejection, and highlights potential experimental strategies to overcome the various rejection responses.

N. Roters, Niveditha Varma, R. Ramm et al. · 0 citations
Review Open access Sep 2026

Reframing Technology and Ethics in Corneal Xenotransplantation: A Scoping Review of Standards and Safety in Ophthalmology

ABSTRACT Xenotransplantation offers a potential solution to the critical global organ shortage by allowing the transplantation of organs from non‐primate animals to humans. To address the critical barriers of biological safety, zoonotic infections, and immunological rejection, this review evaluates current innovations...

S. Saha, Moubani Dutta, Agnihiya Bosu · 0 citations
Review Open access Sep 2026

Multiomic analyses in xenotransplantation: Hypothesis generation and the path toward precision diagnostics.

The use of multiomics as a hypothesis-generating tool to guide next-generation donor-pig design and adjust immunosuppression is summarized, while exploring its contribution to the diagnosis of xenograft rejection.

J. Ladowski, A. Sannier, A. Loupy et al. · 0 citations
#gene editing Open access Oct 2026

Advancing cardiac xenotransplantation: overcoming challenges and ethical considerations for clinical integration

Advanced heart failure affects over 6 million adults in the United States alone. Orthotopic heart transplantation remains the definitive treatment, with over 90% one-year survival and meaningful gains in functional status and quality of life. The therapy is, however, constrained by an intractable supply problem. For de...

A. Abdelrehim, D. Hurst, W. H. Gray et al. · 0 citations
#gene editing Review Open access Sep 2026

Beyond conventional immunosuppression: tailoring perioperative management protocols for clinical xenotransplantation

This review proposes a standardized perioperative management protocol that is applicable to clinical xenotransplantation and addresses consumptive coagulopathy; targeted suppression of macrophage- and neutrophil-driven innate inflammatory cascades, alongside activation of xenoreactive natural killer cells.

Kyu-Hyun Han, J. Yang · 0 citations

Related blog posts

Microsoft Research Blog Nov 12, 2026

Microsoft Research Focus – Edition #98

What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient.  The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.